VOYA Investment Management
KYTX icon

VOYA Investment Management’s Kyverna Therapeutics KYTX Stock Holding History

VOYA Investment Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$380K Sell
44,045
-24,095
-35% -$201K ﹤0.01% 1846
2025
Q4 		$641K Buy
+68,140
New +$506K ﹤0.01% 1647

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

VOYA Investment Management's KYTX Position: Q1 2026 in Review

VOYA Investment Management reduced its Kyverna Therapeutics (KYTX) stake by 35% in Q1 2026, selling an estimated $201K and leaving 44,045 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

VOYA Investment Management first reported a position in KYTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $641K in Q4 2025. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • VOYA Investment Management held 44,045 shares of Kyverna Therapeutics worth $380K as of Q1 2026.
  • VOYA Investment Management sold 24,095 Kyverna Therapeutics shares in Q1 2026, an estimated $201K.
  • Kyverna Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1846 holding.
  • VOYA Investment Management first reported a position in Kyverna Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • VOYA Investment Management's Kyverna Therapeutics position peaked at $641K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.